Related Experiment Video
Updated: Jul 30, 2025

04:41
Author Spotlight: Improving Reproducibility in Vascular Organoids Using ROCK Inhibitors and Microwell Confinement
Published on: December 13, 2024
1.9K
Vascularization of a Bone Organoid Using Dental Pulp Stem Cells
Aonan Li1, Jun-Ichi Sasaki1, Gabriela L Abe2
1Department of Dental Biomaterials, Osaka University Graduate School of Dentistry, Osaka, Japan.
Stem Cells International
|May 18, 2023
Summary
Dental pulp stem cells (DPSCs) enhance bone organoid survival by promoting vascularization. Incorporating DPSCs into bone marrow-derived mesenchymal stem cell (BMSC) constructs significantly reduced necrosis and improved bone regeneration potential.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Stem Cell Biology
Background:
- Scaffold-free bone organoids using bone marrow-derived mesenchymal stem cells (BMSCs) face challenges with cell necrosis due to poor nutrient and oxygen diffusion.
- Dental pulp stem cells (DPSCs) possess inherent vasculogenic potential, differentiating into vascular endothelial lineages.
Purpose of the Study:
- To investigate the potential of DPSCs as a vascular source to improve BMSC survival and enhance bone organoid formation.
- To evaluate the impact of DPSC incorporation on the vasculogenic and osteogenic properties of BMSC constructs.
Main Methods:
- DPSCs were incorporated into BMSC constructs at varying ratios (5%-20%).
- Endothelial differentiation was induced, and vasculogenic characteristics (sprouting, proangiogenic markers, lumen formation) were assessed.
- Osteogenic induction was performed on vascularized constructs, and mineralization was quantified.
Main Results:
- DPSCs exhibited superior sprouting ability and higher proangiogenic marker expression compared to BMSCs.
- DPSC incorporation significantly reduced cell necrosis and improved construct viability, forming lumen-like structures.
- Vascularized BMSC/DPSC constructs showed increased mineralized deposition and a hollow structure compared to BMSC-only constructs.
Conclusions:
- Vascularized, scaffold-free bone organoids can be successfully fabricated by incorporating DPSCs into BMSC constructs.
- The enhanced vascularization by DPSCs improves cell survival and osteogenic capacity, showing promise for bone regenerative medicine.
- This biomimetic approach holds potential for bone defect repair and drug development applications.

